653 related articles for article (PubMed ID: 16532725)
1. [Percutaneous coronary interventions in elderly patients: clinical indications and adjunctive medical treatment. The Italian Drug Evaluation in Angioplasty (IDEA) study].
Bossi I; Piccaluga E; Scatturin M; Corvaja N; Pasquetto G; Steffanon L; Oberhollenzer R; Colombo P; Bolognese L; Savonitto S
G Ital Cardiol (Rome); 2006 Feb; 7(2):136-44. PubMed ID: 16532725
[TBL] [Abstract][Full Text] [Related]
2. Drug therapy during percutaneous coronary interventions in stable and unstable coronary artery disease: the Italian Drug Evaluation in Angioplasty (IDEA) study.
Savonitto S; Ambrosini V; Marzocchi A; Tolaro S; Petronio AS; Galassi AR; Bongo AS; Gaglione A; Bolognese L; ;
Ital Heart J; 2005 Feb; 6(2):106-18. PubMed ID: 15819503
[TBL] [Abstract][Full Text] [Related]
3. [Coronary angioplasty in elderly patients].
Liistro F; Colombo A
Ital Heart J Suppl; 2002 Jan; 3(1):1-8. PubMed ID: 11899566
[TBL] [Abstract][Full Text] [Related]
4. The dilemma of success: percutaneous coronary interventions in patients > or = 75 years of age-successful but associated with higher vascular complications and cardiac mortality.
Assali AR; Moustapha A; Sdringola S; Salloum J; Awadalla H; Saikia S; Ghani M; Hale S; Schroth G; Rosales O; Anderson HV; Smalling RW
Catheter Cardiovasc Interv; 2003 Jun; 59(2):195-9. PubMed ID: 12772238
[TBL] [Abstract][Full Text] [Related]
5. Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE).
Brieger D; Van de Werf F; Avezum A; Montalescot G; Kennelly BM; Granger CB; Goodman SG; Dabbous OH; Agnelli G;
Am Heart J; 2007 Jun; 153(6):960-9. PubMed ID: 17540196
[TBL] [Abstract][Full Text] [Related]
6. Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization.
Lenzen MJ; Boersma E; Bertrand ME; Maier W; Moris C; Piscione F; Sechtem U; Stahle E; Widimsky P; de Jaegere P; Scholte op Reimer WJ; Mercado N; Wijns W;
Eur Heart J; 2005 Jun; 26(12):1169-79. PubMed ID: 15802360
[TBL] [Abstract][Full Text] [Related]
7. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.
Dobrzycki S; Mezyński G; Kralisz P; Prokopczuk P; Nowak K; Kochman W; Zuk J; Bachórzewska-Gajewska H; Sawicki Z; Poniatowski B; Korecki J; Musiał WJ
Kardiol Pol; 2006 Aug; 64(8):793-9; discussion 800-1. PubMed ID: 16981054
[TBL] [Abstract][Full Text] [Related]
8. Primary coronary angioplasty in the elderly.
Feliciano J; Fiarresga AJ; Timóteo AT; Pelicano N; Cacela D; Ferreira R; Ferreira L; Gonçalves JM; Quininha J
Rev Port Cardiol; 2005 Feb; 24(2):205-14. PubMed ID: 15861902
[TBL] [Abstract][Full Text] [Related]
9. Primary angioplasty in patients > or = 75 years old with ST-elevation myocardial infarction - one-year follow-up results.
Ciszewski A; Karcz M; Kepka C; Bekta P; Ksiezycka E; Przyłuski J; Debski A; Witkowski A; Ruzyłło W
Kardiol Pol; 2008 Aug; 66(8):828-33; discussion 834-6. PubMed ID: 18803134
[TBL] [Abstract][Full Text] [Related]
10. Stenting and glycoprotein IIb/IIIa inhibition in patients with acute myocardial infarction undergoing percutaneous coronary intervention: findings from the global registry of acute coronary events (GRACE).
Montalescot G; Van de Werf F; Gulba DC; Avezum A; Brieger D; Kennelly BM; Mazurek T; Spencer F; White K; Gore JM;
Catheter Cardiovasc Interv; 2003 Nov; 60(3):360-7. PubMed ID: 14571488
[TBL] [Abstract][Full Text] [Related]
11. Impact of age on procedural and 1-year outcome in percutaneous transluminal coronary angioplasty: a report from the NHLBI Dynamic Registry.
Cohen HA; Williams DO; Holmes DR; Selzer F; Kip KE; Johnston JM; Holubkov R; Kelsey SF; Detre KM;
Am Heart J; 2003 Sep; 146(3):513-9. PubMed ID: 12947372
[TBL] [Abstract][Full Text] [Related]
12. Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) (from the New York State Angioplasty Registry).
Feldman DN; Gade CL; Slotwiner AJ; Parikh M; Bergman G; Wong SC; Minutello RM;
Am J Cardiol; 2006 Nov; 98(10):1334-9. PubMed ID: 17134624
[TBL] [Abstract][Full Text] [Related]
13. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis.
O'Donoghue M; Antman EM; Braunwald E; Murphy SA; Steg PG; Finkelstein A; Penny WF; Fridrich V; McCabe CH; Sabatine MS; Wiviott SD
J Am Coll Cardiol; 2009 Aug; 54(8):678-85. PubMed ID: 19679245
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and safety of glycoprotein IIb/IIIa inhibitors and clopidogrel alone and in combination in non-ST-segment elevation myocardial infarction (from the National Registry of Myocardial Infarction-4).
Bromberg-Marin G; Marin-Neto JA; Parsons LS; Canto JG; Rogers WJ;
Am J Cardiol; 2006 Nov; 98(9):1125-31. PubMed ID: 17056312
[TBL] [Abstract][Full Text] [Related]
15. In-hospital and one-year outcomes of patients with high-risk acute myocardial infarction treated with thrombolysis or primary coronary angioplasty.
Steffenino G; Santoro GM; Maras P; Mauri F; Ardissino D; Violini R; Chiarella F; Lucci D; Marini M; Baldasseroni S; Maggioni AP;
Ital Heart J; 2004 Feb; 5(2):136-45. PubMed ID: 15086144
[TBL] [Abstract][Full Text] [Related]
16. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of percutaneous coronary interventions in patients with non ST segment elevation acute coronary syndrome in catheterisation laboratory without on-site surgical back-up.
Dudek D; Rakowski T; Legutko J; Mielecki W; Dziewierz A; Bartuś S; Rzeszutko Ł; Sadowski J; Zmudka K; Dubiel JS
Kardiol Pol; 2003 May; 58(5):356-65; discussion: 365. PubMed ID: 14523483
[TBL] [Abstract][Full Text] [Related]
18. Should patients in cardiogenic shock undergo rescue angioplasty after failed fibrinolysis: comparison of primary versus rescue angioplasty in cardiogenic shock patients.
Kunadian B; Vijayalakshmi K; Dunning J; Thornley AR; Sutton AG; Muir DF; Wright RA; Hall JA; de Belder MA
J Invasive Cardiol; 2007 May; 19(5):217-23. PubMed ID: 17476036
[TBL] [Abstract][Full Text] [Related]
19. Optimizing primary PCI beyond "door to intervention time"--are we there yet?
Kaluski E; Maher J; Gerula C; Tsai S; Randhawa P; Saric M; Oghlakian G; Alfano D; Palmaro J; Haider B; Klapholz M
Cardiovasc Revasc Med; 2010; 11(2):84-90. PubMed ID: 20347797
[TBL] [Abstract][Full Text] [Related]
20. [Percutaneous coronary revascularization in patients over eighty: acute and long-term results].
Lettieri C; Buffoli F; Romano M; Aroldi M; Baccaglioni N; Tomasi L; Rosiello R; Agostini F; Kuwornu H; Pepi P; Izzo A; Zanini R
Ital Heart J Suppl; 2005 Sep; 6(9):588-98. PubMed ID: 16281718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
